The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta
Awards/PROJECT GRANT (B)

$64,812,576

Department of Health and Human Services·National Institutes of Health

to WASHINGTON UNIVERSITY, THE

biotechactiveONGOING · MOD OF 2020 CONTRACT
WORK BEGAN2020-09-15·LATEST ACTION2026-05-05·SOURCEUSASPENDING·SOURCE IDASST_NON_R01AG068319_075
Award description

DIAN-TU: TAU NEXT GENERATION PREVENTION TRIAL

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

Funds the DIAN-TU tau prevention trial, a clinical research study testing tau-targeting therapies to prevent Alzheimer's disease in at-risk populations.

Sub-sectors
nih-research-granttau-protein-researchalzheimers-prevention
Why this matters

Tau pathology is central to Alzheimer's; this large NIH investment targets a critical mechanism for disease prevention in preclinical stages.

Supply-chain signal

Drives demand for tau biomarker assays, imaging services, clinical trial infrastructure, and pharmaceutical development partnerships.

U.S.–China competition angle

U.S. leadership in Alzheimer's prevention research; China is also investing heavily in dementia research, making this a competitive scientific priority.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002356.

Period of performance
Start
2020-09-15
End
2027-05-31
Status
activein 379 days
Recipient
WASHINGTON UNIVERSITY, THE
UEI L6NFUM28LQM5
View full profile →
Other awards from this recipient
See all →
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.